SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
fangang
Lv5
1300 积分
2025-03-19 加入
最近求助
最近应助
互助留言
Better efficacy, lower recurrence rate and decreased CD8+TRM with guselkumab treatment for generalized pustular psoriasis: A prospective cohort study from China
19小时前
待确认
High-throughput reactive oxygen species (ROS) assay: An enabling technology for screening the phototoxic potential of pharmaceutical substances
23天前
已完结
High-throughput reactive oxygen species (ROS) assay: An enabling technology for screening the phototoxic potential of pharmaceutical substances
23天前
已关闭
High-throughput reactive oxygen species (ROS) assay: An enabling technology for screening the phototoxic potential of pharmaceutical substances
23天前
已关闭
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn’s Disease and Ulcerative Colitis
1个月前
已完结
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn’s Disease and Ulcerative Colitis
1个月前
已关闭
Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn’s Disease and Ulcerative Colitis
1个月前
已关闭
The changing demographic pattern of multiple sclerosis epidemiology
1个月前
已完结
Incidence of multiple sclerosis in China: A nationwide hospital-based study
1个月前
已完结
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
1个月前
已完结
没有进行任何应助
一个小时都没收到【积分已退回】
23天前
要得急,太慢了点【积分已退回】
23天前
太慢了,几分钟还没反应逼我提高积分【积分已退回】
1个月前
太慢了,重新求助【积分已退回】
1个月前
20多分钟还没找到【积分已退回】
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论